CA950909A - Sulphonylamino-pyrimidines and their preparation - Google Patents

Sulphonylamino-pyrimidines and their preparation

Info

Publication number
CA950909A
CA950909A CA084,840,A CA84840A CA950909A CA 950909 A CA950909 A CA 950909A CA 84840 A CA84840 A CA 84840A CA 950909 A CA950909 A CA 950909A
Authority
CA
Canada
Prior art keywords
sulphonylamino
pyrimidines
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA084,840,A
Other languages
English (en)
Inventor
Felix-Helmut Schmidt
Rudi Weyer
Manfred Hubner
Ruth Heerdt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1929232A external-priority patent/DE1929232C3/de
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of CA950909A publication Critical patent/CA950909A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA084,840,A 1969-06-07 1970-06-05 Sulphonylamino-pyrimidines and their preparation Expired CA950909A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19691929032 DE1929032A1 (de) 1969-06-07 1969-06-07 Blutzuckersenkende Sulfonylaminopyrimidine und Verfahren zu deren Herstellung
DE1929232A DE1929232C3 (de) 1968-07-25 1969-06-10 Verfahren zum Zerkleinern von Schrott

Publications (1)

Publication Number Publication Date
CA950909A true CA950909A (en) 1974-07-09

Family

ID=25757464

Family Applications (1)

Application Number Title Priority Date Filing Date
CA084,840,A Expired CA950909A (en) 1969-06-07 1970-06-05 Sulphonylamino-pyrimidines and their preparation

Country Status (7)

Country Link
AT (2) AT298499B (enrdf_load_stackoverflow)
CA (1) CA950909A (enrdf_load_stackoverflow)
CH (2) CH544770A (enrdf_load_stackoverflow)
DE (1) DE1929032A1 (enrdf_load_stackoverflow)
FR (1) FR2052940B1 (enrdf_load_stackoverflow)
GB (1) GB1249447A (enrdf_load_stackoverflow)
NL (1) NL7008247A (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
AT298499B (de) 1972-05-10
FR2052940B1 (enrdf_load_stackoverflow) 1974-08-09
CH544770A (de) 1974-01-15
CH539650A (de) 1973-09-14
NL7008247A (enrdf_load_stackoverflow) 1970-12-09
GB1249447A (en) 1971-10-13
DE1929032A1 (de) 1970-12-17
FR2052940A1 (enrdf_load_stackoverflow) 1971-04-16
AT296998B (de) 1972-03-10

Similar Documents

Publication Publication Date Title
IL34383A0 (en) 2-acylimidazoles and their preparation
CA979460A (en) Phenoxy-hydroxypropylamines and their preparation
CA817915A (en) Sodium-tetramethylammonium aluminosilicate and preparation
CA892576A (en) Aminolignosulfonates and preparation thereof
CA811733A (en) Thionophosphates and thionophosphonates and their preparation
CA825174A (en) 5-acyloxyuracils and their preparation
CA950909A (en) Sulphonylamino-pyrimidines and their preparation
CA806266A (en) Polyisoureaethers and their preparation
CA827172A (en) Trialkylsilylphenyldisiloxanes and preparation
CA809669A (en) Indolomorphans and preparation thereof
CA819760A (en) Phenoxyhalopropanols and preparation thereof
CA803519A (en) Azabenzocycloalkane-n-carboxamidines and preparation thereof
AU445948B2 (en) 9-fluoro-16-fluoromethyleneprednisolone-21-oenanthate and preparation thereof
CA948631A (en) Preparation of n-trityl-imidazoles and n-trityl-triazoles
AU1108970A (en) 9-fluoro-16-fluoromethyleneprednisolone-21-oenanthate and preparation thereof
CA828161A (en) Gentamicin-tetracycline derivatives and their preparation
AU453210B2 (en) Pleuromutalin derivatives and their preparation
CA824155A (en) Peri-substituted thiazobicycloal-kanes and the preparation thereof
AU451503B2 (en) Dibenzodiasepines and pyridobenzo-diozepines
CA808659A (en) Pyrazinoylguanidines and pyrazinamidoguanidines
CA822680A (en) Azaspirodecanediones and azaspiroundecanediones
CA995239A (en) Phenylthioaralkylamides and 2-phenylthio-benzylamides
AU404824B2 (en) 3-oxo-13 b-alkyl-5[10]- gonenes and their preparation
AU402469B2 (en) 3-oxo-17b-hydroxy-13 b-alkyl-5 [10]-gonenes and their preparation
CA813927A (en) Isocyanatophenols and the preparation of ureidophenols